NVP-BEZ235, A DUAL PI3K/MTOR INHIBITOR SYNERGISTICALLY POTENTIATES ANTITUMOR EFFECT OF CISPLATIN IN BLADDER CANCER CELLS

被引：0
|
作者：
Park, Hong Seok
Yoon, Cheol Yong
Cheon, Jun
机构：
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2014年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A206 / A206
页数：1
相关论文
共 50 条
  • [1] NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells
    Moon, Du G.
    Lee, Sang E.
    Oh, Mi M.
    Lee, Sang C.
    Jeong, Seong J.
    Hong, Sung K.
    Yoon, Cheol Y.
    Byun, Seok S.
    Park, Hong S.
    Cheon, Jun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 1027 - 1035
  • [2] Radiosensitization by the Dual PI3K/mTOR inhibitor NVP-BEZ235
    Cerniglia, George J.
    Karar, Jayashree
    Koumenis, Constantinos
    Maity, Amit
    CANCER RESEARCH, 2012, 72
  • [3] Radiosensitization by the Dual PI3K/mTOR Inhibitor NVP-BEZ235
    Maity, A.
    Cerniglia, G. J.
    Karar, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S84 - S85
  • [4] SYNTHESIS AND PROCESS OPTIMIZATION OF PI3K/MTOR DUAL INHIBITOR NVP-BEZ235
    Xu, T. S.
    Lei, F.
    Tao, H.
    Li, J. Q.
    Zhang, Z. W.
    Wang, L. X.
    Xu, S.
    Zheng, P. W.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 31 - 31
  • [5] Effect of NVP-BEZ235, a dual PI3K/mTOR inhibitor, on chemotherapy and antiangiogenic response in pancreatic cancer
    Ostapoff, Katherine T.
    Awasthi, Niranjan
    Yen, Peter L.
    Zhang, Changhua
    Schwarz, Margaret A.
    Brekken, Rolf A.
    Schwarz, Roderich
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [6] Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
    Lin, Shu-Fu
    Huang, Yu-Yao
    Lin, Jen-Der
    Chou, Ting-Chao
    Hsueh, Chuen
    Wong, Richard J.
    PLOS ONE, 2012, 7 (10):
  • [7] The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma
    Bhende, P. M.
    Park, S. I.
    Lim, M. S.
    Dittmer, D. P.
    Damania, B.
    LEUKEMIA, 2010, 24 (10) : 1781 - 1784
  • [8] The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma
    P M Bhende
    S I Park
    M S Lim
    D P Dittmer
    B Damania
    Leukemia, 2010, 24 : 1781 - 1784
  • [9] Combination strategy of gemcitabine with the dual PI3K/mTOR inhibitor NVP-BEZ235 in pancreatic cancer cells.
    Hausmann, E.
    Glienke, W.
    Bergmann, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] In vivo antitumor activity of NVP-BEZ235, a dual PI3K/mTOR inhibitor, and RAD001 (everolimus), an mTOR inhibitor, in endometrial cancer
    Shoji, Keiko
    Oda, Katsutoshi
    Nakagawa, Shunsuke
    Ikeda, Yuji
    Kashiyama, Tomoko
    Miyamoto, Yuichiro
    Tanikawa, Michihiro
    Kuramoto, Hiroyuki
    Hiraike-Wada, Osamu
    Yano, Tetsu
    Taketani, Yuji
    CANCER RESEARCH, 2011, 71
12345